I am a
Home I AM A Search Login

Papers of the Week


Papers: 15 Feb 2020 - 21 Feb 2020


Animal Studies, Pharmacology/Drug Development


2020 Feb 14


Neurogastroenterol Motil

Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.

Authors

Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T
Neurogastroenterol Motil. 2020 Feb 14:e13819.
PMID: 32056324.

Abstract

Lipopolysaccharide (LPS) or repeated water avoidance stress (WAS) induces visceral allodynia and colonic hyperpermeability via corticotropin-releasing factor (CRF) and proinflammatory cytokines, which is considered to be a rat irritable bowel syndrome (IBS) model. As losartan is known to inhibit proinflammatory cytokine release, we hypothesized that it improves these visceral changes.